BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Theratechnologies, Ferrer sales and marketing update

Theratechnologies granted Grupo Ferrer commercialization rights to Egrifta tesamorelin in Europe, Russia, South Korea, Taiwan, Turkmenistan and Tajikistan to treat excess abdominal fat in HIV patients with lipodystrophy, with an...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >